Cojean S - Search Results

1

Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.

Bosc D, Mouray E, Cojean S, Franco CH, Loiseau PM, Freitas-Junior LH, Moraes CB, Grellier P, Dubois J. Bosc D, et al. Among authors: cojean s. Eur J Med Chem. 2016 Feb 15;109:173-86. doi: 10.1016/j.ejmech.2015.12.045. Epub 2015 Dec 29. Eur J Med Chem. 2016. PMID: 26774924

2

Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.

Bories C, Cojean S, Huteau F, Loiseau PM. Bories C, et al. Among authors: cojean s. Biomed Pharmacother. 2008 Mar;62(3):164-7. doi: 10.1016/j.biopha.2007.12.006. Epub 2008 Jan 14. Biomed Pharmacother. 2008. PMID: 18249083

3

Mechanism of interaction of sitamaquine with Leishmania donovani.

Coimbra ES, Libong D, Cojean S, Saint-Pierre-Chazalet M, Solgadi A, Le Moyec L, Duenas-Romero AM, Chaminade P, Loiseau PM. Coimbra ES, et al. Among authors: cojean s. J Antimicrob Chemother. 2010 Dec;65(12):2548-55. doi: 10.1093/jac/dkq371. Epub 2010 Oct 18. J Antimicrob Chemother. 2010. PMID: 20956354

4

Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.

Loiseau PM, Cojean S, Schrével J. Loiseau PM, et al. Among authors: cojean s. Parasite. 2011 May;18(2):115-9. doi: 10.1051/parasite/2011182115. Parasite. 2011. PMID: 21678786 Free PMC article. Review.

5

Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.

Audisio D, Messaoudi S, Cojean S, Peyrat JF, Brion JD, Bories C, Huteau F, Loiseau PM, Alami M. Audisio D, et al. Among authors: cojean s. Eur J Med Chem. 2012 Jun;52:44-50. doi: 10.1016/j.ejmech.2012.03.003. Epub 2012 Mar 16. Eur J Med Chem. 2012. PMID: 22472166

6

Synthesis and antiprotozoal activity of original porphyrin precursors and derivatives.

Abada Z, Cojean S, Pomel S, Ferrié L, Akagah B, Lormier AT, Loiseau PM, Figadère B. Abada Z, et al. Among authors: cojean s. Eur J Med Chem. 2013 Sep;67:158-65. doi: 10.1016/j.ejmech.2013.06.002. Epub 2013 Jun 12. Eur J Med Chem. 2013. PMID: 23851117

7

Adsorption of antisense oligonucleotides targeting malarial topoisomerase II on cationic nanoemulsions optimized by a full factorial design.

Bruxel F, Bochot A, Diel D, Wild L, Carvalho EL, Cojean S, Loiseau PM, Fattal E, Teixeira HF. Bruxel F, et al. Among authors: cojean s. Curr Top Med Chem. 2014;14(9):1161-71. doi: 10.2174/1568026614666140329230835. Curr Top Med Chem. 2014. PMID: 24678706

8

Sitamaquine-resistance in Leishmania donovani affects drug accumulation and lipid metabolism.

Imbert L, Cojean S, Libong D, Chaminade P, Loiseau PM. Imbert L, et al. Among authors: cojean s. Biomed Pharmacother. 2014 Sep;68(7):893-7. doi: 10.1016/j.biopha.2014.08.009. Epub 2014 Aug 19. Biomed Pharmacother. 2014. PMID: 25201056

9

Targeting sterol metabolism for the development of antileishmanials.

Pomel S, Cojean S, Loiseau PM. Pomel S, et al. Among authors: cojean s. Trends Parasitol. 2015 Jan;31(1):5-7. doi: 10.1016/j.pt.2014.11.007. Epub 2014 Dec 12. Trends Parasitol. 2015. PMID: 25498194

10

"Squalenoylcurcumin" nanoassemblies as water-dispersible drug candidates with antileishmanial activity.

Cheikh-Ali Z, Caron J, Cojean S, Bories C, Couvreur P, Loiseau PM, Desmaële D, Poupon E, Champy P. Cheikh-Ali Z, et al. Among authors: cojean s. ChemMedChem. 2015 Feb;10(2):411-8. doi: 10.1002/cmdc.201402449. Epub 2014 Dec 18. ChemMedChem. 2015. PMID: 25523035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters